Join
Live feed
·
INSIDERFilingvia Quantisnow
Aspire Biopharma Holdings Inc. logo

Director Fell Donald G. increased direct ownership by 5% to 20,000 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ASBP (Aspire Biopharma Holdings Inc.) and more on Quantisnow.